New drugs have made America’s deadliest cancer more treatable than ever. So why aren’t they reaching patients?
In part 2, Deborah Doroshow, MD, PhD, discusses early clinical trial access, emerging lung cancer therapies, and barriers to ...
Abenacianine, a fluorescent imaging agent, received FDA fast track status for enhancing tumor visualization during lung cancer surgery, showing safety and efficacy in phase 2 trials. Alecensa ...
From breathless to breathing freely. NASA engineer and mother Jodi Graf is grateful to celebrate another Mother’s Day after ...
About half of people diagnosed with metastatic non-small-cell lung cancer never receive treatment, despite advances in ...
Dr. Joshua Sabari tells CURE that surgery, radiation and systemic therapy can affect the lungs, and he urges exercise and reporting new symptoms early. In an interview with CURE, Dr. Joshua Sabari, a ...
Lung adenocarcinoma is the most common type of lung cancer diagnosed in the U.S. Just over half of all non-small-cell lung cancers (NSCLCs) are adenocarcinomas. Finding out that you're at risk of lung ...
A new foundation run by Wojcicki's family is searching for answers about why more nonsmokers are getting lung cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results